CoChat

Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis

Open access

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. While it is well-accepted that inflammation is central to NAFLD pathogenesis, the immune pathway(s) orchestrating disease progression are poorly defined. Notably, IL-17RA signaling, via IL-17A, plays an important role in obesity-driven NAFLD pathogenesis. However, the role of the IL-17F, another IL-17RA ligand, in NAFLD pathogenesis has not been examined. Further, the cell types expressing IL-17RA and producing IL-17RA ligands in the pathogenesis of NAFLD have not been defined. Here, IL-17RA-/-, IL-17A-/-, IL-17F-/- and wild-type (WT) mice were fed either standard chow diet or methionine and choline deficient diet (MCDD)--a diet known to induce steatosis and hepatic inflammation through beta-oxidation dysfunction--and hepatic inflammation and NAFLD progression were subsequently quantified. MCDD feeding augmented hepatic IL-17RA expression and significantly increased hepatic infiltration of macrophages and IL-17A and IL-17F producing CD4+ and CD8+ T cells in WT mice. In contrast, IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice, despite increased steatosis, exhibited significant protection from hepatocellular damage compared to WT controls. Protection from hepatocellular damage correlated with decreased levels of hepatic T-cell and macrophage infiltration and decreased expression of inflammatory mediators associated with NAFLD. In sum, our results indicate that the IL-17 axis also plays a role in a MCDD-induced model of NAFLD pathogenesis. Further, we show for the first time that IL-17F, and not only IL-17A, plays an important role in NAFLD driven inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0149783

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 MCDD-driven NAFLD augments resident liver, but not immune cell IL-17RA expression and is associated with increased hepatic macrophage recruitment and activation. 8 week old male C57BL/6 mice (n = 4/condition) were placed on MCDD or chow diet for 4 weeks. (A) Hepatic IL-17RA mRNA expression. (B) Percent of hepatic immune cells expressing IL-17RA. (C) Mean fluorescent intensity of hepatic immune cells expressing IL-17RA. (D) Percent of hepatic immune cells (CD45+) expressing CD11b and F4/80. (E) Percent of hepatic macrophages (F4/80+) producing TNF. Dotted line = chow fed. Solid line = MCDD fed. (F) Serum ALT levels. AU = Arbitrary Units, as compared to beta actin. Data represent means + SE from a single experiment. Student t test *P < 0.05, **P < 0.01, ***P < 0.001.
Fig 1 MCDD-driven NAFLD augments resident liver, but not immune cell IL-17RA expression and is associated with increased hepatic macrophage recruitment and activation. 8 week old male C57BL/6 mice (n = 4/condition) were placed on MCDD or chow diet for 4 weeks. (A) Hepatic IL-17RA mRNA expression. (B) Percent of hepatic immune cells expressing IL-17RA. (C) Mean fluorescent intensity of hepatic immune cells expressing IL-17RA. (D) Percent of hepatic immune cells (CD45+) expressing CD11b and F4/80. (E) Percent of hepatic macrophages (F4/80+) producing TNF. Dotted line = chow fed. Solid line = MCDD fed. (F) Serum ALT levels. AU = Arbitrary Units, as compared to beta actin. Data represent means + SE from a single experiment. Student t test *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central
Fig 2 MCDD-driven NAFLD alters hepatic levels of IL-17A and IL-17F production. 8 week old male C57BL/6 mice (n = 4/condition) were placed on MCDD or chow diet for 4 weeks. (A) IL-17A and IL-17F production was determined in cells following the gating on: CD45+, TCRβ+, NK1.1-, CD4+ or CD8+. (B) Percent of hepatic immune cells (CD45+) producing IL-17A. (C) Percent of hepatic immune cells (CD45+) producing IL-17F. (D) Percent of hepatic TCRβ+ cells (CD4+ or CD8+ T cells) producing IL-17A. (E) Percent of hepatic TCRβ+ cells (CD4+ or CD8+ T cells) producing IL-17F. (F) Mean fluorescent intensity of IL-17A in TCRβ+ cells (CD4+ or CD8+ T cells). (G) Mean fluorescent intensity of IL-17F in TCRβ+ cells (CD4+ or CD8+ T cells). (H) Percent of hepatic immune cells (CD45+) expressing GR-1 and CD11b. Data represent means + SE; a representative of two separate experiments. Student t test **P < 0.01.
Fig 2 MCDD-driven NAFLD alters hepatic levels of IL-17A and IL-17F production. 8 week old male C57BL/6 mice (n = 4/condition) were placed on MCDD or chow diet for 4 weeks. (A) IL-17A and IL-17F production was determined in cells following the gating on: CD45+, TCRβ+, NK1.1-, CD4+ or CD8+. (B) Percent of hepatic immune cells (CD45+) producing IL-17A. (C) Percent of hepatic immune cells (CD45+) producing IL-17F. (D) Percent of hepatic TCRβ+ cells (CD4+ or CD8+ T cells) producing IL-17A. (E) Percent of hepatic TCRβ+ cells (CD4+ or CD8+ T cells) producing IL-17F. (F) Mean fluorescent intensity of IL-17A in TCRβ+ cells (CD4+ or CD8+ T cells). (G) Mean fluorescent intensity of IL-17F in TCRβ+ cells (CD4+ or CD8+ T cells). (H) Percent of hepatic immune cells (CD45+) expressing GR-1 and CD11b. Data represent means + SE; a representative of two separate experiments. Student t test **P < 0.01.CC BY · PubMed Central
Fig 3 IL-17 axis deficiency does not modulate systemic effects of MCDD feeding. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Weight loss as percent of starting body weight. (B) Total daily food intake. (C) Serum triglyceride levels. (D) Serum cholesterol levels. (E) Liver weight as a percentage of total body weight. (F) Hepatic mitochondrial oxygen consumption rate in mice fed chow. (G) Hepatic mitochondrial oxygen consumption rate in mice fed MCDD. (H) Hepatic SREBP-1c mRNA expression. (I) Hepatic PPARα mRNA expression. (J) Hepatic Lipe mRNA expression. (K) Hepatic KLF15 mRNA expression. AU = Arbitrary Units, as compared to beta actin. Data represents means + SE; a representative of two separate experiments. Student t test *P < 0.05, ** P < 0.01, *** P < 0.001.
Fig 3 IL-17 axis deficiency does not modulate systemic effects of MCDD feeding. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Weight loss as percent of starting body weight. (B) Total daily food intake. (C) Serum triglyceride levels. (D) Serum cholesterol levels. (E) Liver weight as a percentage of total body weight. (F) Hepatic mitochondrial oxygen consumption rate in mice fed chow. (G) Hepatic mitochondrial oxygen consumption rate in mice fed MCDD. (H) Hepatic SREBP-1c mRNA expression. (I) Hepatic PPARα mRNA expression. (J) Hepatic Lipe mRNA expression. (K) Hepatic KLF15 mRNA expression. AU = Arbitrary Units, as compared to beta actin. Data represents means + SE; a representative of two separate experiments. Student t test *P < 0.05, ** P < 0.01, *** P < 0.001.CC BY · PubMed Central
Fig 4 IL-17 axis deficiency augments hepatic steatosis, but protects from hepatocellular damage. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Hepatic triglyceride levels. (B) Hepatic SCD-1 mRNA expression. (C) Serum alanine transaminase (ALT) levels. AU = Arbitrary units, as compared to beta actin. Data represent means + SE; a representative of two separate experiments. Student t test *P < 0.05, ** P < 0.01, *** P < 0.001.
Fig 4 IL-17 axis deficiency augments hepatic steatosis, but protects from hepatocellular damage. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Hepatic triglyceride levels. (B) Hepatic SCD-1 mRNA expression. (C) Serum alanine transaminase (ALT) levels. AU = Arbitrary units, as compared to beta actin. Data represent means + SE; a representative of two separate experiments. Student t test *P < 0.05, ** P < 0.01, *** P < 0.001.CC BY · PubMed Central
Fig 5 IL-17 Axis signaling regulates T cell infiltration to the liver. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Representative liver histology (H&E staining; 40x). Marked difference in the level and type of steatosis and inflammation between WT and IL-17RA-/-, IL-17A-/- and IL-17F-/- mice on MCDD. No differences were noted between genotypes on a chow diet. (B) Representative immunohistochemistry staining of CD3+ T cells in the livers of WT chow, along with WT, IL-17RA-/-, IL-17A-/- and IL-17F-/- mice on MCDD and average number of CD3+ cells per 20x field. (C) Hepatic CXCL10 mRNA expression. AU = Arbitrary units, as compared to beta actin. Data represents means + SE; a representative of two separate experiments. Student t test *P < 0.05, **P < 0.01, ***P < 0.001.
Fig 5 IL-17 Axis signaling regulates T cell infiltration to the liver. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Representative liver histology (H&E staining; 40x). Marked difference in the level and type of steatosis and inflammation between WT and IL-17RA-/-, IL-17A-/- and IL-17F-/- mice on MCDD. No differences were noted between genotypes on a chow diet. (B) Representative immunohistochemistry staining of CD3+ T cells in the livers of WT chow, along with WT, IL-17RA-/-, IL-17A-/- and IL-17F-/- mice on MCDD and average number of CD3+ cells per 20x field. (C) Hepatic CXCL10 mRNA expression. AU = Arbitrary units, as compared to beta actin. Data represents means + SE; a representative of two separate experiments. Student t test *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central
Fig 6 The IL-17 axis regulates macrophage infiltration to the liver. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Representative immunohistochemistry staining of CD68+ macrophages in the livers of WT mice fed chow and WT, IL-17RA-/-, IL-17A-/- and IL-17F-/- mice on MCDD and average number of CD68+ cells per 20x field. (B-D) Hepatic mRNA expression: (B) CCL2; (C) CCL22; (D) TNFα. (E) Representative Sirius Red staining of the livers from WT, IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice fed MCDD. AU = Arbitrary units, as compared to beta actin. Data represents means + SE; a representative of two separate experiments. Student t test *P < 0.05, **P < 0.01, ***P < 0.001.
Fig 6 The IL-17 axis regulates macrophage infiltration to the liver. 8 week old male IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice on a C57BL/6 background and WT controls (n = 4-8/condition) were placed on MCDD or chow diet for 4 weeks. (A) Representative immunohistochemistry staining of CD68+ macrophages in the livers of WT mice fed chow and WT, IL-17RA-/-, IL-17A-/- and IL-17F-/- mice on MCDD and average number of CD68+ cells per 20x field. (B-D) Hepatic mRNA expression: (B) CCL2; (C) CCL22; (D) TNFα. (E) Representative Sirius Red staining of the livers from WT, IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice fed MCDD. AU = Arbitrary units, as compared to beta actin. Data represents means + SE; a representative of two separate experiments. Student t test *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. F Meng, 2012, Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice, Gastroenterology, 143, 765, 10.1053/j.gastro.2012.05.049 · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • Research Institute for Biomedical Sciences, Tokyo University of Science (JP)
  • The University of Texas MD Anderson Cancer Center (US)
Corresponding author
Divanovic, Senad
Venue
PLOS ONE
Published
2016-02-19
Volume
11
Issue
2
Pages
e0149783
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2283265313
Cited by
116
References
49
Citations by year
2026: 3 · 2025: 8 · 2024: 13 · 2023: 12 · 2022: 12 · 2021: 25 · 2020: 7 · 2019: 8 · 2018: 9 · 2017: 11 · 2016: 7
FWCI
10.87
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Cincinnati Children's Hospital Medical Center (P30DK078392, R01DK099222)
  • National Institutes of Health (DK078392)
  • Japan Society for the Promotion of Science (15H05787, 24220011)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK099222, P30DK078392)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
non-alcoholic fatty liver disease, IL-17A, IL-17F, liver inflammation, methionine-choline-deficient diet, steatosis, hepatocyte injury, macrophage infiltration, T cell infiltration
MeSH terms
Animals, Choline, Diet, Disease Models, Animal, Hepatitis, Macrophages, Male, Methionine, Mice, Inbred C57BL, T-Lymphocytes, Signal Transduction, Interleukin-17, Mice, Receptors, Interleukin-17, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis. https://app.cochat.ai/papers/10.1371/journal.pone.0149783
The paper
Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S. (2016). Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis. PLOS ONE. https://doi.org/10.1371/journal.pone.0149783

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.